These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21593311)

  • 1. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family.
    Anwar S; Peters O; Millership S; Ninkina N; Doig N; Connor-Robson N; Threlfell S; Kooner G; Deacon RM; Bannerman DM; Bolam JP; Chandra SS; Cragg SJ; Wade-Martins R; Buchman VL
    J Neurosci; 2011 May; 31(20):7264-74. PubMed ID: 21593311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.
    Senior SL; Ninkina N; Deacon R; Bannerman D; Buchman VL; Cragg SJ; Wade-Martins R
    Eur J Neurosci; 2008 Feb; 27(4):947-57. PubMed ID: 18333965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.
    Al-Wandi A; Ninkina N; Millership S; Williamson SJ; Jones PA; Buchman VL
    Neurobiol Aging; 2010 May; 31(5):796-804. PubMed ID: 19097673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction.
    Greten-Harrison B; Polydoro M; Morimoto-Tomita M; Diao L; Williams AM; Nie EH; Makani S; Tian N; Castillo PE; Buchman VL; Chandra SS
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19573-8. PubMed ID: 20974939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice.
    Ninkina N; Tarasova TV; Chaprov KD; Roman AY; Kukharsky MS; Kolik LG; Ovchinnikov R; Ustyugov AA; Durnev AD; Buchman VL
    Neurobiol Aging; 2020 Jul; 91():76-87. PubMed ID: 32224067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo.
    Somayaji M; Cataldi S; Choi SJ; Edwards RH; Mosharov EV; Sulzer D
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32701-32710. PubMed ID: 33273122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
    Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
    PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
    Ninkina N; Millership SJ; Peters OM; Connor-Robson N; Chaprov K; Kopylov AT; Montoya A; Kramer H; Withers DJ; Buchman VL
    J Biol Chem; 2021 Dec; 297(6):101375. PubMed ID: 34736896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.
    Abeliovich A; Schmitz Y; Fariñas I; Choi-Lundberg D; Ho WH; Castillo PE; Shinsky N; Verdugo JM; Armanini M; Ryan A; Hynes M; Phillips H; Sulzer D; Rosenthal A
    Neuron; 2000 Jan; 25(1):239-52. PubMed ID: 10707987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
    Pavia-Collado R; Rodríguez-Aller R; Alarcón-Arís D; Miquel-Rio L; Ruiz-Bronchal E; Paz V; Campa L; Galofré M; Sgambato V; Bortolozzi A
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease.
    Bellucci A; Navarria L; Falarti E; Zaltieri M; Bono F; Collo G; Spillantini MG; Missale C; Spano P
    PLoS One; 2011; 6(12):e27959. PubMed ID: 22163275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein.
    Chadchankar H; Ihalainen J; Tanila H; Yavich L
    Brain Res; 2011 Mar; 1382():37-44. PubMed ID: 21276428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
    Chandra S; Fornai F; Kwon HB; Yazdani U; Atasoy D; Liu X; Hammer RE; Battaglia G; German DC; Castillo PE; Südhof TC
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14966-71. PubMed ID: 15465911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
    Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain reward in the absence of alpha-synuclein.
    Oksman M; Tanila H; Yavich L
    Neuroreport; 2006 Jul; 17(11):1191-4. PubMed ID: 16837852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
    Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
    Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
    Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
    J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.